China SXT Pharmaceuticals, Inc. — Company profile
Healthcare · Drug Manufacturers - Specialty & Generic · China
Last price 3.55 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 46.91K
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers Advanced TCMP, including Directly-Oral-TCMP, and After-Soaking-Oral TCMP; Fine TCMP and Regular TCMP products; and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
Details
| Name | China SXT Pharmaceuticals, Inc. |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 56 |
| Founded | 2005 |
| Ipo Date | 2019-01-04 |
| Ceo | Feng Zhou |
| Country | China |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| Ipo Price | 4.00 |
| Isin | VGG2161P1817 |
| Cusip | G2161P181 |
| Cik | 0001723980 |
| Sic | 2834 |
| Share Class | Class A Shares |
Key executives
| Name | Title |
|---|---|
| Sze Beng Lim | Co-Chief Executive Officer |
| Feng Zhou | Chairman of the Board and Co-Chief Executive Officer |
| Xiaodong Pan | Chief Financial Officer |
| Jun Zheng | Executive Director |
Contact
| Address | 178 Taidong Road North, Taizhou, 225300, China |
| Phone | 86 523 8629 8290 |
| Website | https://www.sxtchina.com |